Logo Image
News
Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Media
Around the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsShortsTraining AcademyTreatment Algorithms with the Oncology BrothersVideos
Conferences
Publications
All JournalsEditorial BoardFor AuthorsYear in Review
More
Events
Frontline ForumSatellite Sessions
CME/CE
Resources
Awareness MonthThe Bispecifics NetworkNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career Center

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • Events
  • CME/CE
  • Resources
  • Career Center
  • Subscribe
  • Adverse Effects
  • Artificial Intelligence
  • Brain Cancer
  • Breast Cancer
    • HER2-Positive Breast Cancer
    • Triple-Negative Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Esophageal Cancer
    • Pancreatic Cancer
    • Gastric Cancer
    • Liver Cancer
  • Genitourinary Cancers
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Ovarian Cancer
    • Cervical Cancer
  • Head & Neck Cancer
  • Hematologic Oncology
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
  • Infection
    • Vaccines
  • Leukemia
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Non-Small Cell Lung Cancer (NSCLC)
  • Lymphoma
  • Neuroendocrine Tumors
  • Oncology
  • Pediatric Cancers
  • Psycho-Oncology
  • Radiation Oncology
  • Sarcoma
  • Screening
  • Skin Cancer & Melanoma
  • Surgery
  • Thyroid Cancer
Spotlight -
Psycho-Oncology|
Artificial Intelligence|
Radiation Oncology|
Surgery
Advertisement

Ann M. Mauer, MD

Advertisement

Articles by Ann M. Mauer, MD

Phase I Study of Docetaxel and Concomitant Chest Radiation

ByEverett E. Vokes, MD,Ann M. Mauer, MD,Daniel J. Haraf, MD,Gregory A. Masters, MD,Philip C. Hoffman, MD,Harvey M. Golomb, MD,Sylvia Watson, RN
July 1st 1997

Data from the Radiation Therapy Oncology Groupand Eastern Cooperative Oncology Group indicate that increased survival

Advertisement

Latest Updated Articles

  • Phase I Study of Docetaxel and Concomitant Chest Radiation
    Phase I Study of Docetaxel and Concomitant Chest Radiation

    July 1st 1997



Advertisement
Advertisement

Trending on CancerNetwork

1

ASCO 2026: Key Genitourinary Oncology Trials to Watch For

2

Sac-TMT Combo Improves PFS vs Pembrolizumab in NSCLC

3

Elranatamab Shows Strong Efficacy Signal in Smoldering Multiple Myeloma

4

Pembrolizumab Plus Chemotherapy Shows Sustained Survival in Advanced EC

5

Six NACT Cycles Before Surgery Fail to Improve DFS in Advanced Ovarian Cancer

  • About
  • Advertise
  • CureToday.com
  • OncLive.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Editorial
  • Contact
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us